Pasar al contenido principal
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
En afiliación con HIV.gov
Main navigation
  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Español (Spanish)
  • English
  1. Inicio
  2. Search Results
Search Results 41 – 60 of 3231
Cabotegravir / Rilpivirine
https://clinicalinfo.hiv.gov/drugs/cabotegravir-rilpivirine/paciente
Cabotegravir / Rilpivirina
https://clinicalinfo.hiv.gov/drugs/cabotegravir-rilpivirine/paciente
Cabotegravir / Rilpivirine
https://clinicalinfo.hiv.gov/node/11181
Fostemsavir
https://clinicalinfo.hiv.gov/node/11188
Cabotegravir
https://clinicalinfo.hiv.gov/node/11189
Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/alafenamida-de-tenofovir/paciente
Alafenamida de tenofovir
https://clinicalinfo.hiv.gov/drugs/alafenamida-de-tenofovir/paciente
Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/node/11195
What to Start: Initial Combination Antiretroviral Regimens
https://clinicalinfo.hiv.gov/node/11203
What to Start: Protease Inhibitor–Based Regimens
https://clinicalinfo.hiv.gov/node/11204
What to Start: Advantages and Disadvantages of Antiretroviral Components of Initial Antiretroviral Therapy
https://clinicalinfo.hiv.gov/node/11205
What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal
https://clinicalinfo.hiv.gov/node/11206
What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios
https://clinicalinfo.hiv.gov/node/11207
What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
https://clinicalinfo.hiv.gov/node/11208
What to Start: Integrase Strand Transfer Inhibitor Regimens
https://clinicalinfo.hiv.gov/node/11209
What to Start: Nucleoside Reverse Transcriptase Inhibitor Options
https://clinicalinfo.hiv.gov/node/11211
Drug-Drug Interactions: HIV-1 gp120 Inhibitors and Other Drugs
https://clinicalinfo.hiv.gov/node/11212
All Archived Guidelines
https://clinicalinfo.hiv.gov/node/11229
Adult and Adolescent ARV Archive
https://clinicalinfo.hiv.gov/node/11230
Adult and Adolescent Opportunistic Infection Archive
https://clinicalinfo.hiv.gov/node/11231

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 1
  • Página 2
  • Página actual 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • …
  • Siguiente página ›
  • Última página »

Conéctese con nosotros

Footer menu

  • Inicio
  • Sobre Clinicalinfo
  • Guías
  • Medicamentos
  • Glosario
  • Noticias
  • Recursos
  • Contáctenos
  • Patrocinadores
  • Aviso de no discriminación
  • Accesibilidad
  • El descargo de responsabilidad
  • Mapa del sitio
  • Declaración de privacidad
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Ley de Acceso a Información

Proporcionado en colaboración con la Oficina de Investigación del SIDA de los NIH.